Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma
Open Access
- 1 January 2013
- journal article
- Published by Korean Dermatological Association and The Korean Society for Investigative Dermatology in Annals of Dermatology
- Vol. 25 (2) , 135-144
Abstract
Perrot CY, et al. Ann Dermatol. 2013 May;25(2):135-144. http://dx.doi.org/10.5021/ad.2013.25.2.135Keywords
This publication has 94 references indexed in Scilit:
- Restored expression of the atypical heat shock protein H11/HspB8 inhibits the growth of genetically diverse melanoma tumors through activation of novel TAK1-dependent death pathwaysCell Death & Disease, 2012
- Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapyNature Materials, 2012
- Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced CancerMolecular Therapy, 2012
- Transcription factor Dlx2 protects from TGFβ‐induced cell‐cycle arrest and apoptosisThe EMBO Journal, 2011
- Identification of a novel cell binding site of periostin involved in tumour growthEuropean Journal of Cancer, 2011
- A Flexible Multiplex Bead-Based Assay for Detecting Germline CDKN2A and CDK4 Variants in Melanoma-Prone KindredsJournal of Investigative Dermatology, 2011
- Intronic miR-211 Assumes the Tumor Suppressive Function of Its Host Gene in MelanomaMolecular Cell, 2010
- Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-β PathwaysCell, 2009
- Genetic risk factors for melanomaHuman Genetics, 2009
- Mutations of the BRAF gene in human cancerNature, 2002